SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part I–carcinoma of the cervix, ovary, vagina and vulva. Cancer. 2004; 100: 000000.
  • 2
    Tyldesley S, Boyd C, Shulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001; 49: 973985.
  • 3
    Delaney G, Barton M, Jacob S, Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 2003; 4: 120128.
  • 4
    Delaney G, Barton B, Jacob S. Estimation of an optimal radiotherapy utilization rate for breast cancer: a review of the evidence. Cancer. 2003; 98: 19771986.
  • 5
    Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys. 2002; 53: 12401253.
  • 6
    Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma. A review of the evidence. Cancer. 2004; 100: 12931301.
  • 7
    Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys. 2003; 56: 12951307.
  • 8
    Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys. 2003; 55: 5163.
  • 9
    National Cancer Institute. PDQ Cancer information summaries: treatment of endometrial cancer [monograph online]. Available from URL: www.nci.nih.gov [accessed March 8, 2002].
  • 10
    FIGO Committee on Gynecologic Oncology. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynecol Obstet. 2000; 70: 209262.
  • 11
    BC Cancer Agency. Cancer management guidelines for cancer of the endometrium [monograph online]. Available from URL: http://www.bccancer.bc.ca [accessed March 8, 2002].
  • 12
    National Comprehensive Cancer Network. Clinical practice guidelines in oncology -v.1.2002–uterine cancers [monograph online]. Available from URL: www.nccn.org [accessed February 5, 2003].
  • 13
    Thomas R, Blake P. Endometrial carcinoma: adjuvant locoregional therapy. Clin Oncol. 1996; 8: 140145.
  • 14
    European School of Oncology START State of the Art Oncology in Europe. Endometrial cancer [monograph online]. 2001. Available from URL: http://www.startoncology.net[accessed March 8, 2002].
  • 15
    Nag S, Erickson B, Parikh S, Gupta N, Varia M, Glasgow G. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 2000; 48: 779790.
  • 16
    Australian Institute of Health and Welfare (AIHW) and Australasian Institute of Cancer Registries (AICR). Cancer in Australia 1998. Cancer Series 17, CAN 12. 2001. Canberra: Australian Institute of Health and Welfare (AIHW) and Australasian Institute of Cancer Registries, 2001.
  • 17
    National Cancer Institute (Cancer Statistics Branch). SEER Cancer Incidence Public-Use Database, 1973-1999. Bethesda, MD: U.S. Department of Health and Human Services, 2002.
  • 18
    American College of Surgeons. National Cancer Database. Available from URL: http://www.facs.org/cancer/databases.html [accessed March 2003].
  • 19
    SA Cancer Registry. Epidemiology of cancer in South Australia. Cancer Series No 22. Adelaide,South Australia: South Australian Cancer Registry, 2000.
  • 20
    Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A. An analysis of approaches to the treatment of endometrial cancer in Western Europe: a CTF study. Eur J Cancer. 1995; 31A: 19931997.
  • 21
    Kennedy AW, Austin JM, Look KY, Munger CB. The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrial cancer: initial experiences. Gynecol Oncol. 2000; 79: 379398.
  • 22
    Gretz HF, Economos K, Husain A, et al. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol. 1996; 61: 409415.
  • 23
    Cirisano FD, Robboy SJ, Dodge RK, et al. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol. 2000; 77: 5565.
  • 24
    Roila F, Lupattelli M, Sassi M, et al. Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol. 1991; 2: 437439.
  • 25
    Ayhan A, Tuncer ZS, Tuncer R, Yuce K, Kucukali T. Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases. Eur J Obstet Gynecol Reprod Biol. 1994; 57: 167170.
  • 26
    Salvesen HB, Akslen LA, Iversen T, Iversen OE. Recurrence of endometrial carcinoma and the value of routine follow-up. Br J Obstet Gynaecol. 1997; 104: 13021307.
  • 27
    Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol. 1984; 17: 85103.
  • 28
    Shumsky AG, Stuart GCE, Brasher PM, Nation JG, Robertson DI. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol. 1994; 55: 229233.
  • 29
    Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ. Significance of true surgical pathologic staging: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1999; 181: 3134.
  • 30
    Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P. The role of adjuvant radiotherapy in carcinoma of the endometrium - results in 550 patients with pathologic Stage I disease. Gynecol Oncol. 1998; 70: 247254.
  • 31
    Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys. 1997; 38: 373380.
  • 32
    Calais G, Descamps P, Vitu L, et al. Lymphadenectomy in the management of endometrial carcinoma Stage I and II. Retrospective study of 155 cases. Clin Oncol (R Coll Radiol) 1990; 2: 318323.
  • 33
    Eltabbakh GH, Moore AD. Survival of women with surgical Stage II endometrial cancer. Gynecol Oncol. 1999; 74: 8085.